Published in J Gastroenterol Hepatol on January 01, 2004
Cryptogenic chronic hepatitis and its changing guise in adults. Dig Dis Sci (2011) 1.50
Molecular diagnostic and pathogenesis of hereditary hemochromatosis. Int J Mol Sci (2012) 1.22
Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India. World J Gastroenterol (2007) 0.96
Identification of ferroportin disease in the Indian subcontinent. Gut (2005) 0.88
Involvement of GTP-binding "G" proteins in transport through the Golgi stack. Cell (1987) 5.28
Dissection of a single round of vesicular transport: sequential intermediates for intercisternal movement in the Golgi stack. Cell (1989) 3.78
Protein kinase D regulates the fission of cell surface destined transport carriers from the trans-Golgi network. Cell (2001) 3.19
A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol (2013) 3.19
Gbetagamma-mediated regulation of Golgi organization is through the direct activation of protein kinase D. Cell (1999) 2.67
Signaling via mitogen-activated protein kinase kinase (MEK1) is required for Golgi fragmentation during mitosis. Cell (1998) 2.61
Complete vesiculation of Golgi membranes and inhibition of protein transport by a novel sea sponge metabolite, ilimaquinone. Cell (1993) 2.44
The formation of Golgi stacks from vesiculated Golgi membranes requires two distinct fusion events. Cell (1995) 2.35
Bile duct obstruction due to portal biliopathy in extrahepatic portal hypertension: surgical management. Br J Surg (1998) 2.07
A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology (2007) 2.07
The curious status of the Golgi apparatus. Cell (1998) 1.95
Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol (2007) 1.88
Fatty acyl-coenzyme A is required for budding of transport vesicles from Golgi cisternae. Cell (1989) 1.81
Golgi spectrin: identification of an erythroid beta-spectrin homolog associated with the Golgi complex. J Cell Biol (1994) 1.79
Endoscopic sclerotherapy using absolute alcohol. Gut (1985) 1.73
Acute renal failure in falciparum malaria--increasing prevalence in some areas of India--a need for awareness. Nephrol Dial Transplant (1996) 1.71
Frequency and clinical profile of precore and surface hepatitis B mutants in Asian-Indian patients with chronic liver disease. Am J Gastroenterol (1996) 1.70
Blood transfusion practices in India: results of a national survey. Indian J Gastroenterol (2000) 1.70
Recruitment of protein kinase D to the trans-Golgi network via the first cysteine-rich domain. EMBO J (2001) 1.68
Clinical, biochemical and histological profile of nonalcoholic steatohepatitis. Indian J Gastroenterol (2001) 1.67
P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India. Cancer (2000) 1.63
A specific activation of the mitogen-activated protein kinase kinase 1 (MEK1) is required for Golgi fragmentation during mitosis. J Cell Biol (2000) 1.61
Polo-like kinase is required for the fragmentation of pericentriolar Golgi stacks during mitosis. Proc Natl Acad Sci U S A (2001) 1.59
The mechanism of Golgi segregation during mitosis is cell type-specific. Proc Natl Acad Sci U S A (1997) 1.58
Coagulation profile and platelet function in patients with extrahepatic portal vein obstruction and non-cirrhotic portal fibrosis. J Gastroenterol Hepatol (2001) 1.52
Dietary and nutritional abnormalities in alcoholic liver disease: a comparison with chronic alcoholics without liver disease. Am J Gastroenterol (1997) 1.51
Portal biliopathy. J Gastroenterol Hepatol (2001) 1.51
Role of yoga in modifying certain cardiovascular functions in type 2 diabetic patients. J Assoc Physicians India (2004) 1.51
The haemodynamic response to propranolol in cirrhosis with arterial hypertension: a comparative analysis with normotensive cirrhotic patients. Aliment Pharmacol Ther (2010) 1.50
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin. J Viral Hepat (2013) 1.46
Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol (2001) 1.45
What is safe blood? J Assoc Physicians India (2000) 1.45
Ligand binding by the p150,95 antigen of U937 monocytic cells: properties in common with complement receptor type 3 (CR3). Eur J Immunol (1986) 1.43
Increased frequency of gallstones in cirrhotic and non-cirrhotic portal hypertension. J Assoc Physicians India (2002) 1.42
Location of Golgi membranes with reference to dividing nuclei in syncytial Drosophila embryos. Proc Natl Acad Sci U S A (1994) 1.41
High seroprevalence and clinical significance of hepatitis B and C infection in hospitalized patients with alcoholic cirrhosis. J Assoc Physicians India (2002) 1.39
Recombinant interferon therapy in Indian children with HBV related chronic liver disease. Indian Pediatr (2002) 1.39
ARF signaling: a potential role for phospholipase D in membrane traffic. Cell (1993) 1.39
Endoscopic biliary drainage by nasobiliary drain or by stent placement in patients with acute cholangitis. Endoscopy (2005) 1.39
Regulation of Golgi structure through heterotrimeric G proteins. Cell (1997) 1.38
Inferior vena caval obstruction due to amoebic liver abscess. J Assoc Physicians India (1982) 1.33
The organisation of the Golgi apparatus. Curr Opin Cell Biol (1998) 1.32
Expression of complement factor H on the cell surface of the human monocytic cell line U937. Eur J Immunol (1985) 1.32
Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis. J Hepatol (2000) 1.32
Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis. J Viral Hepat (2012) 1.21
Effect of alternate nostril breathing exercise on cardiorespiratory functions. Nepal Med Coll J (2008) 1.21
Role of HBV genotype in predicting response to lamivudine therapy in patients with chronic hepatitis B. Indian J Gastroenterol (2005) 1.20
Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol Ther (2009) 1.19
Rectal histology in acute bacillary dysentery. Gastroenterology (1986) 1.19
Comparison of the two time schedules for endoscopic sclerotherapy: a prospective randomised controlled study. Gut (1986) 1.16
Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence. J Hepatol (1997) 1.16
Familial prevalence among first-degree relatives of celiac disease in North India. Dig Liver Dis (2007) 1.15
A preliminary report on the role of yoga asanas on oxidative stress in non-insulin dependent diabetes mellitus. Indian J Clin Biochem (2001) 1.14
Primary parotid tuberculosis: varied clinical presentations. Oral Dis (2006) 1.14
Membrane fusion in organelle biogenesis. Curr Opin Cell Biol (1996) 1.11
A case report of olanzapine-induced fecal incontinence. J Clin Psychiatry (2003) 1.10
Acute pancreatitis associated with viral hepatitis: a report of six cases with review of literature. Am J Gastroenterol (1999) 1.09
The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension. Hepatology (1995) 1.08
Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial. J Viral Hepat (2013) 1.07
A case of hepatocellular carcinoma associated with troublesome hypoglycemia: management by cytoreduction using percutaneous ethanol injection. Am J Gastroenterol (1998) 1.07
Balloon tamponade in the management of bleeding oesophageal varices. Ann R Coll Surg Engl (1984) 1.06
Choledochal cysts--differences in children and adults. Br J Surg (1996) 1.06
Endoscopic management of liver abscesses and cysts that communicate with intrahepatic bile ducts. Endoscopy (2006) 1.05
Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol (2001) 1.04
Salmonellosis associated with abdominal aortic aneurysm. Arch Intern Med (1974) 1.04
Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status. Dig Dis Sci (2006) 1.04
Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients. J Viral Hepat (1999) 1.03
Periampullary gangliocytic paraganglioma. J Clin Gastroenterol (2001) 1.01
NF-kappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx. Oncogene (2009) 1.01
Unusual foreign bodies in ear, nose and throat practice. Indian J Otolaryngol Head Neck Surg (1999) 1.01
Pattern of alcohol-related liver disease in dependent alcoholics: the Indian dimension. Br J Addict (1988) 1.01
Comparative evaluation of bone marrow aspirate particle smears, imprints and biopsy sections. J Postgrad Med (1990) 1.01
Role of NAD+ and ADP-ribosylation in the maintenance of the Golgi structure. J Cell Biol (1997) 0.99
Choledocholithiasis associated with portal biliopathy in patients with extrahepatic portal vein obstruction: management with endoscopic sphincterotomy. Gastrointest Endosc (1995) 0.99
Prevalence of hepatitis B infection within family contacts of chronic liver disease patients--does HBeAg positivity really matter? J Assoc Physicians India (2002) 0.98
Do umbilical vein catheterization and sepsis lead to portal vein thrombosis? A prospective, clinical, and sonographic evaluation. J Pediatr Gastroenterol Nutr (1993) 0.98
Repeated endoscopic sclerotherapy for active variceal bleeding. Ann Surg (1985) 0.98
Acute renal failure in eastern India. Nephrol Dial Transplant (1995) 0.98
Corrosive oesophageal strictures following acid ingestion: clinical profile and results of endoscopic dilatation. J Gastroenterol Hepatol (1991) 0.98
Reconstitution of vesiculated Golgi membranes into stacks of cisternae: requirement of NSF in stack formation. J Cell Biol (1995) 0.97
Cytomorphology of filariasis revisited. Expansion of the morphologic spectrum and coexistence with other lesions. Acta Cytol (2001) 0.97
Hepatic dysfunction in patients with extrahepatic portal venous obstruction. Liver Int (2003) 0.96
Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases. QJM (2008) 0.96
Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease: a preliminary report. J Gastroenterol Hepatol (2001) 0.95
Follow-up of patients after variceal eradication. A comparison of patients with cirrhosis, noncirrhotic portal fibrosis, and extrahepatic obstruction. Ann Surg (1986) 0.95